ClinicalTrials.Veeva

Menu

Effect of Probiotics on Periodontitis Stage III Grade C Molar-incisor Pattern (RCT)

A

Al-Azhar University

Status and phase

Completed
Phase 3

Conditions

Periodontal Diseases

Treatments

Drug: placebo formula
Drug: Probiotic Formula

Study type

Interventional

Funder types

Other

Identifiers

NCT06253988
AUAREC202300010-2

Details and patient eligibility

About

the research highlight the effectiveness of probiotics as adjuncts to SRP in the treatment of periodontitis stage III grade C molar-incisor pattern

Full description

Background data : Periodontitis is a common disease that represents a public health problem. Aggregatibacter actinomycetemcomitans (A. a ) especially the JP2 genotype plays a major role in the pathogenesis of periodontitis. The aim of this study is to evaluate the effect of topically applied probiotics on the management of periodontitis stage III grade C molar-incisor pattern.

Methods: Sixty-five patients having periodontitis stage III grade C molar-incisor pattern. Screening for A. actinomycetemcomians (A.a) and the JP2 genotype was done using conventional polymerase chain reaction (PCR). Patients positive for (A. a) were randomly divided into two groups. Group I: received conventional periodontal treatment combined with topically applied probiotic, while Group II: received conventional periodontal treatment only. Both groups were evaluated microbiologically and clinically. Quantitative assessment of A. a levels was done by real time PCR (qPCR) at baseline as well as one week, 4 weeks, and 12 weeks after treatment. Clinical parameters were assessed before treatment as well as 3,6 and 9 months after treatment.

Enrollment

65 patients

Sex

All

Ages

10 to 28 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients have periodontitis stage III grade C molar-incisor pattern .

Exclusion criteria

  • Pregnant or nursing women,
  • smokers,
  • patients received periodontal therapy,
  • systemic antimicrobials or anti-inflammatory drugs in the last six
  • patients with unacceptable oral hygiene

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

65 participants in 2 patient groups, including a placebo group

Group probiotic
Active Comparator group
Description:
received conventional periodontal treatment combined with topically applied probiotic
Treatment:
Drug: Probiotic Formula
Group placebo
Placebo Comparator group
Description:
received conventional periodontal treatment only.
Treatment:
Drug: placebo formula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems